miRNA dysregulation in cancer: Towards a mechanistic understanding

Frontiers in Genetics

Volumn 5, Issue MAR, 2014, Pages

  Palanichamy, Jayanth Kumar ^a   Rao, Dinesh S ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Genetic redundancy; MicroRNA profiling; MicroRNAs; Non genetic heterogeneity; Single cell studies

Indexed keywords

MICRORNA; RNA;

BIOGENESIS; CARCINOGENESIS; CELL HETEROGENEITY; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MOLECULAR GENETICS; NEOPLASM; NON GENETIC VARIATION; PATHOGENESIS; PHENOTYPE; REVIEW; TRANSCRIPTOMICS;

EID: 84897978086     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00054     Document Type: Review

References (91)

1. Adiconis, X., Borges-Rivera, D., Satija, R., DeLuca, D. S., Busby, M. A., Berlin, A. M., et al. (2013). Comparative analysis of RNA sequencing methods for degraded or low-input samples. Nat. Methods 10, 623-629. doi: 10.1038/nmeth.2483
2. Almeida, M. I., Nicoloso, M. S., Zeng, L., Ivan, C., Spizzo, R., Gafà, R., et al. (2012). Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 142, 886-896. doi: 10.1053/j.gastro.2011.12.047
3. Aqeilan, R. I., Calin, G. A., and Croce, C. M. (2010). miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ. 17, 215-220. doi: 10.1038/cdd.2009.69
4. Babar, I. A., Cheng, C. J., Booth, C. J., Liang, X., Weidhaas, J. B., Saltzman, W. M., et al. (2012). Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc. Natl. Acad. Sci. U.S.A. 109, E1695-E1704. doi: 10.1073/pnas.1201516109
5. Baker, M. (2010). microRNA profiling: separating signal from noise. Nat. Methods 7, 687-692. doi: 10.1038/nmeth0910-687
6. Boldin, M. P., Taganov, K. D., Rao, D. S., Yang, L., Zhao, J. L., Kalwani, M., et al. (2011). miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208, 1189-1201. doi: 10.1084/jem.20101823
7. Borchert, G. M., Holton, N. W., and Larson, E. D. (2011). Repression of human activation induced cytidine deaminase by miR-93 and miR-155. BMC Cancer 11:347. doi: 10.1186/1471-2407-11-347
8. Bustin, S. A., Benes, V., Garson, J., Hellemans, J., Huggett, J., Kubista, M., et al. (2013). The need for transparency and good practices in the qPCR literature. Nat. Methods 10, 1063-1067. doi: 10.1038/nmeth.2697
9. Calin, G. A., and Croce, C. M. (2006). microRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866. doi: 10.1038/nrc1997
10. Calin, G. A., and Croce, C. M. (2009). Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes. Blood 114, 4761-4770. doi: 10.1182/blood-2009-07-192740
11. Calin, G. A., Liu, C. G., Sevignani, C., Ferracin, M., Felli, N., Dumitru, C. D., et al. (2004). microRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. U.S.A. 101, 11755-11760. doi: 10.1073/pnas.0404432101
12. Cancer Genome Atlas Research Network. (2013). Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059-2074. doi: 10.1056/NEJMoa1301689
13. Castellano, L., and Stebbing, J. (2013). Deep sequencing of small RNAs identifies canonical and non-canonical miRNA and endogenous siRNAs in mammalian somatic tissues. Nucleic Acids Res. 41, 3339-3351. doi: 10.1093/nar/gks1474
14. Chang, H. H., Hemberg, M., Barahona, M., Ingber, D. E., and Huang, S. (2008). Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 453, 544-547. doi: 10.1038/nature06965
15. Chaudhuri, A. A., So, A. Y., Mehta, A., Minisandram, A., Sinha, N., Jonsson, V. D., et al. (2012). Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A. Proc. Natl. Acad. Sci. U.S.A. 109, 4233-4238. doi: 10.1073/pnas.1200677109
16. Chen, L., Cui, B., Zhang, S., Chen, G., Croce, C. M., and Kipps, T. J. (2008). Association between the proficiency of B-cell receptor signaling and the relative expression levels of ZAP-70, SHIP-1, and Mir-155 in chronic lymphocytic leukemia. Blood 112, 3155.
17. Chim, C. S., Wong, K. Y., Qi, Y., Loong, F., Lam, W. L., Wong, L. G., et al. (2010). Epigenetic inactivation of the miR-34a in hematological malignancies. Carcinogenesis 31, 745-750. doi: 10.1093/carcin/bgq033
18. Choi, Y. J., Lin, C. P., Ho, J. J., He, X., Okada, N., Bu, P., et al. (2011). miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat. Cell Biol. 13, 1353-1360. doi: 10.1038/ncb2366
19. Christoffersen, N. R., Shalgi, R., Frankel, L. B., Leucci, E., Lees, M., Klausen, M., et al. (2010). p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ. 17, 236-245. doi: 10.1038/cdd.2009.109
20. Concepcion, C. P., Han, Y. C., Mu, P., Bonetti, C., Yao, E., D'Andrea, A., et al. (2012). Intact p53-dependent responses in miR-34-deficient mice. PLoS Genet. 8:e1002797. doi: 10.1371/journal.pgen.1002797
21. Corney, D. C., Hwang, C. I., Matoso, A., Vogt, M., Flesken-Nikitin, A., Godwin, A. K., et al. (2010). Frequent downregulation of miR-34 family in human ovarian cancers. Clin. Cancer Res. 16, 1119-1128. doi: 10.1158/1078-0432.CCR-09-2642
22. Costinean, S., Sandhu, S. K., Pedersen, I. M., Tili, E., Trotta, R., Perrotti, D., et al. (2009). Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. Blood 114, 1374-1382. doi: 10.1182/blood-2009-05-220814
23. Costinean, S., Zanesi, N., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N., et al. (2006). Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 103, 7024-7029. doi: 10.1073/pnas.0602266103
24. Croce, C. M. (2009). Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10, 704-714. doi: 10.1038/nrg2634
25. Eis, P. S., Tam, W., Sun, L., Chadburn, A., Li, Z., Gomez, M. F., et al. (2005). Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U.S.A. 102, 3627-3632. doi: 10.1073/pnas.0500613102
26. Elcheva, I., Goswami, S., Noubissi, F. K., and Spiegelman, V. S. (2009). CRD-BP protects the coding region of betaTrCP1 mRNA from miR-183-mediated degradation. Mol. Cell 35, 240-246. doi: 10.1016/j.molcel.2009.06.007
27. Epis, M. R., Giles, K. M., Kalinowski, F. C., Barker, A., Cohen, R. J., and Leedman, P. J. (2012). Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells. J. Biol. Chem. 287, 35251-35259. doi: 10.1074/jbc. M112.374686
28. Fabbri, M., Bottoni, A., Shimizu, M., Spizzo, R., Nicoloso, M. S., Rossi, S., et al. (2011). Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 305, 59-67. doi: 10.1001/jama.2010.1919
29. Gaj, T., Gersbach, C. A., and Barbas, C. F. III. (2013). ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 31, 397-405. doi: 10.1016/j.tibtech.2013.04.004
30. Garzon, R., Calin, G. A., and Croce, C. M. (2009). microRNAs in Cancer. Annu. Rev. Med. 60, 167-179. doi: 10.1146/annurev.med.59.053006.104707
31. Garzon, R., Marcucci, G., and Croce, C. M. (2010). Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov. 9, 775-789. doi: 10.1038/nrd3179
32. Git, A., Dvinge, H., Salmon-Divon, M., Osborne, M., Kutter, C., Hadfield, J., et al. (2010). Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 16, 991-1006. doi: 10.1261/rna.1947110
33. Goswami, S., Tarapore, R. S., Teslaa, J. J., Grinblat, Y., Setaluri, V., and Spiegelman, V. S. (2010). microRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding region determinant-binding protein. J. Biol. Chem. 285, 20532-20540. doi: 10.1074/jbc. M110.109298
34. Grosshans, H., and Chatterjee, S. (2010). microRNAses and the regulated degradation of mature animal miRNAs. Adv. Exp. Med. Biol. 700, 140-155. doi: 10.1007/978-1-4419-7823-3_12
35. Guan, D., Zhang, W., Zhang, W., Liu, G. H., and Belmonte, J. C. (2013). Switching cell fate, ncRNAs coming to play. Cell Death Dis. 4:e464. doi: 10.1038/cddis.2012.196
36. Han, Y. C., Park, C. Y., Bhagat, G., Zhang, J., Wang, Y., Fan, J. B., et al. (2010). microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J. Exp. Med. 207, 475-489. doi: 10.1084/jem.20090831
37. Hatley, M. E., Patrick, D. M., Garcia, M. R., Richardson, J. A., Bassel-Duby, R., van Rooij, E., et al. (2010). Modulation of K-Ras-dependent lung tumorigenesis by microRNA-21. Cancer Cell 18, 282-293. doi: 10.1016/j.ccr.2010.08.013
38. He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., et al. (2005). A microRNA polycistron as a potential human oncogene. Nature 435, 828-833. doi: 10.1038/nature03552
39. Helwak, A., Kudla, G., Dudnakova, T., and Tollervey, D. (2013). Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153, 654-665. doi: 10.1016/j.cell.2013.03.043
40. Hermeking, H. (2010). The miR-34 family in cancer and apoptosis. Cell Death Differ. 17, 193-199. doi: 10.1038/cdd.2009.56
41. Hornbeck, P. (2001). Double-immunodiffusion assay for detecting specific antibodies. Curr. Protoc. Immunol. Chap. 2:Unit 2.3. doi: 10.1002/0471142735.im0203s00
42. Huang, V., and Li, L. C. (2012). miRNA goes nuclear. RNA Biol. 9, 269-273. doi: 10.4161/rna.19354
43. Huffaker, T. B., Hu, R., Runtsch, M. C., Bake, E., Chen, X., Zhao, J., et al. (2012). Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity. Cell Rep. 2, 1697-1709. doi: 10.1016/j.celrep.2012.10.025
44. Jin, H. Y., Oda, H., Lai, M., Skalsky, R. L., Bethel, K., Shepherd, J., et al. (2013). microRNA-17~92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways. EMBO J. 32, 2377-2391. doi: 10.1038/emboj.2013.178
45. Karlsen, T. A., and Brinchmann, J. E. (2013). Liposome delivery of microRNA-145 to mesenchymal stem cells leads to immunological off-target effects mediated by RIG-I. Mol. Ther. 21, 1169-1181. doi: 10.1038/mt.2013.55
46. Karreth, F. A., and Pandolfi, P. P. (2013). ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov. 3, 1113-1121. doi: 10.1158/2159-8290.CD-13-0202
47. Kasashima, K., Nakamura, Y., and Kozu, T. (2004). Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells. Biochem. Biophys. Res. Commun. 322, 403-410. doi: 10.1016/j.bbrc.2004.07.130
48. Kim, V. N., Han, J., and Siomi, M. C. (2009). Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10, 126-139. doi: 10.1038/nrm2632
49. Klein, U., Lia, M., Crespo, M., Siegel, R., Shen, Q., Mo, T., et al. (2010). The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17, 28-40. doi: 10.1016/j.ccr.2009.11.019
50. Krol, J., Loedige, I., and Filipowicz, W. (2010). The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11, 597-610. doi: 10.1038/nrg2843
51. Kumar, M. S., Pester, R. E., Chen, C. Y., Lane, K., Chin, C., Lu, J., et al. (2009). Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev. 23, 2700-2704. doi: 10.1101/gad.1848209
52. Lee, R. C., Feinbaum, R. L., and Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854. doi: 10.1016/0092-8674(93)90529-Y
53. Matkovich, S. J., Van Booven, D. J., Eschenbacher, W. H., and Dorn, G. W. II. (2011). RISC RNA sequencing for context-specific identification of in vivo microRNA targets. Circ. Res. 108, 18-26. doi: 10.1161/CIRCRESAHA.110.233528
54. Medina, P. P., Nolde, M., and Slack, F. J. (2010). OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467, 86-90. doi: 10.1038/nature09284
55. Meister, G. (2013). Argonaute proteins: functional insights and emerging roles. Nat. Rev. Genet. 14, 447-459. doi: 10.1038/nrg3462
56. Mestdagh, P., Van Vlierberghe, P., De Weer, A., Muth, D., Westermann, F., Speleman, F., et al. (2009). A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 10, R64. doi: 10.1186/gb-2009-10-6-r64
57. Mittal, N., and Zavolan, M. (2014). Seq and CLIP through the miRNA world. Genome Biol. 15, 202. doi: 10.1186/gb4151
58. Mukherji, S., Ebert, M. S., Zheng, G. X., Tsang, J. S., Sharp, P. A., and van Oudenaarden, A. (2011). microRNAs can generate thresholds in target gene expression. Nat. Genet. 43, 854-859. doi: 10.1038/ng.905
59. Nana-Sinkam, S. P., and Croce, C. M. (2013). Clinical applications for microRNAs in cancer. Clin. Pharmacol. Ther. 93, 98-104. doi: 10.1038/clpt.2012.192
60. O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., and Baltimore, D. (2009). Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. U.S.A. 106, 7113-7118. doi: 10.1073/pnas.0902636106
61. O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., Gibson, W. S., Balazs, A. B., and Baltimore, D. (2010a). microRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc. Natl. Acad. Sci. U.S.A 107, 14235-14240. doi: 10.1073/pnas.1009798107
62. O'Connell, R. M., Kahn, D., Gibson, W. S., Round, J. L., Scholz, R. L., Chaudhuri, A. A., et al. (2010b). microRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33, 607-619. doi: 10.1016/j.immuni.2010.09.009
63. O'Connell, R. M., Zhao, J. L., and Rao, D. S. (2011). microRNA function in myeloid biology. Blood 118, 2960-2969. doi: 10.1182/blood-2011-03-291971
64. Park, C. Y., Choi, Y. S., and McManus, M. T. (2010). Analysis of microRNA knockouts in mice. Hum. Mol. Genet. 19, R169-R175. doi: 10.1093/hmg/ddq367
65. Pauli, A., Rinn, J. L., and Schier, A. F. (2011). Non-coding RNAs as regulators of embryogenesis. Nat. Rev. Genet. 12, 136-149. doi: 10.1038/nrg2904
66. Pritchard, C. C., Cheng, H. H., and Tewari, M. (2012). microRNA profiling: approaches and considerations. Nat. Rev. Genet. 13, 358-369. doi: 10.1038/nrg3198
67. Rao, D. S., O'Connell, R. M., Chaudhuri, A. A., Garcia-Flores, Y., Geiger, T. L., and Baltimore, D. (2010). microRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity 33, 48-59. doi: 10.1016/j.immuni.2010.06.013
68. Ravi, A., Gurtan, A. M., Kumar, M. S., Bhutkar, A., Chin, C., Lu, V., et al. (2012). Proliferation and tumorigenesis of a murine sarcoma cell line in the absence of DICER1. Cancer Cell 21, 848-855. doi: 10.1016/j.ccr.2012.04.037
69. Ritchie, W., Rasko, J. E., and Flamant, S. (2013). microRNA target prediction and validation. Adv. Exp. Med. Biol. 774, 39-53. doi: 10.1007/978-94-007-5590-1_3
70. Roderburg, C., Urban, G. W., Bettermann, K., Vucur, M., Zimmermann, H., Schmidt, S., et al. (2011). micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53, 209-218. doi: 10.1002/hep.23922
71. Siemens, H., Jackstadt, R., Kaller, M., and Hermeking, H. (2013). Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness. Oncotarget 4, 1399-1415.
72. Singh, S., Narang, A. S., and Mahato, R. I. (2011). Subcellular fate and off-target effects of siRNA, shRNA, and miRNA. Pharm. Res. 28, 2996-3015. doi: 10.1007/s11095-011-0608-1
73. Song, S. J., Ito, K., Ala, U., Kats, L., Webster, K., Sun, S. M., et al. (2013). The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 13, 87-101. doi: 10.1016/j.stem.2013.06.003
74. Stahlberg, A., Kubista, M., and Pfaffl, M. (2004). Comparison of reverse transcriptases in gene expression analysis. Clin. Chem. 50, 1678-1680. doi: 10.1373/clinchem.2004.035469
75. Starczynowski, D. T., Kuchenbauer, F., Argiropoulos, B., Sung, S., Morin, R., Muranyi, A., et al. (2010). Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat. Med. 16, 49-58. doi: 10.1038/nm.2054
76. Szabo, G., and Bala, S. (2013). microRNAs in liver disease. Nat. Rev. Gastroenterol. Hepatol. 10, 542-552. doi: 10.1038/nrgastro.2013.87
77. Thai, T. H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., et al. (2007). Regulation of the germinal center response by microRNA-155. Science 316, 604-608. doi: 10.1126/science.1141229
78. Thomson, D. W., Bracken, C. P., and Goodall G. J. (2011). Experimental strategies for microRNA target identification. Nucleic Acids Res. 39, 6845-6853. doi: 10.1093/nar/gkr330
79. Trissal, M., Silva, J., Wylie, T., Hundal, J., McGrath, S., Magrini, V., et al. (2013). Dysregulation and recurrent mutation of miRNA-142 in de novo AML. Blood 122, 472.
80. Uchino, K., Takeshita, F., Takahashi, R. U., Kosaka1, N., Fujiwara, K., Naruoka, H., et al. (2013). Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression. Mol. Ther. 21, 610-619. doi: 10.1038/mt.2012.269
81. van Kouwenhove, M., Kedde, M., and Agami, R. (2011). microRNA regulation by RNA-binding proteins and its implications for cancer. Nat. Rev. Cancer 11, 644-656. doi: 10.1038/nrc3107
82. Vickers, K. C., Sethupathy, P., Baran-Gale, J., and Remaley, A. T. (2013). Complexity of microRNA function and the role of isomiRs in lipid homeostasis. J. Lipid Res. 54, 1182-1191. doi: 10.1194/jlr. R034801
83. Wightman, B., Ha, I., and Ruvkun, G. (1993). Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75, 855-862. doi: 10.1016/0092-8674(93)90530-4
84. Witwer, K. W. (2013). Data submission and quality in microarray-based microRNA profiling. Clin. Chem. 59, 392-400. doi: 10.1373/clinchem.2012.193813
85. Wu, M., Piccini, M., Koh, C. Y., Lam, K. S., and Singh, A. K. (2013). Single cell microRNA analysis using microfluidic flow cytometry. PLoS ONE 8:e55044. doi: 10.1371/journal.pone.0055044
86. Xiao, C., and Rajewsky, K. (2009). microRNA control in the immune system: basic principles. Cell 136, 26-36. doi: 10.1016/j.cell.2008.12.027
87. Xiao, C., Calado, D. P., Galler, G., Thai, T. H., Patterson, H. C., Wang, J., et al. (2007). MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131, 146-159. doi: 10.1016/j.cell.2007.07.021
88. Xiong, Y., Fang, J. H., Yun, J. P., Yang, J., Zhang, Y., Jia, W. H., et al. (2010). Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51, 836-845. doi: 10.1002/hep.23380
89. Yang, X., Du, W. W., Li, H., Liu, F., Khorshidi, A., Rutnam, Z. J., et al. (2013). Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion. Nucleic Acids Res. 41, 9688-9704. doi: 10.1093/nar/gkt680
90. Zhao, J. L., Rao, D. S., Boldin, M. P., Taganov, K. D., O'Connell, R. M., and Baltimore, D. (2011). NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc. Natl. Acad. Sci. U.S.A. 108, 9184-9189. doi: 10.1073/pnas.1105398108
91. Zhao, J. L., Rao, D. S., O'Connell, R. M., Garcia-Flores, Y., and Baltimore, D. (2013). microRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice. Elife 2:e00537. doi: 10.7554/eLife.00537